The Liver Cancer Study Group of Japan, Kyoto, Japan.
Hepatol Res. 2007 Sep;37(9):676-91. doi: 10.1111/j.1872-034X.2007.00119.x.
In the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan, 18 213 individuals were newly registered as patients with primary liver cancer at 645 medical institutions over a period of 2 years (from 1 January 2002 to 31 December 2003). Of these patients, 94.2% had hepatocellular carcinoma (HCC) and 4.1% had intrahepatic cholangiocarcinoma (ICC). In addition, 24 705 follow-up patients were registered in the survey. Epidemiological and clinicopathological factors, diagnosis and treatment were investigated in the newly registered patients, and the cumulative survival rates of newly registered patients in the 12th to 17th follow-up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment. The data obtained in this follow-up survey should contribute to future research and medical practice for primary liver cancer.
在日本第 17 次全国原发性肝癌随访调查中，645 家医疗机构在 2 年期间（2002 年 1 月 1 日至 2003 年 12 月 31 日）新登记了 18213 例原发性肝癌患者。这些患者中，94.2%为肝细胞癌（HCC），4.1%为肝内胆管癌（ICC）。此外，该调查还登记了 24705 例随访患者。对新登记的患者进行了流行病学和临床病理因素、诊断和治疗的调查，并对 1992 年至 2003 年期间进行的第 12 至 17 次随访调查中，按组织学类型（HCC、ICC 和 HCC 与 ICC 合并）和背景因素及治疗进行分层，计算了新登记患者的累积生存率。本随访调查获得的数据应有助于原发性肝癌的未来研究和医疗实践。
